Collectively, these findings define a Tn‐R–Nav1.6 signaling axis at NORs that governs Aβ biogenesis, thus identifying the GEDC sequence as a promising therapeutic target for AD intervention. The gene discussed is TNR; the disease is Alzheimer disease.